-+ 0.00%
-+ 0.00%
-+ 0.00%

NuWays initiates Gallmetzer HealthCare with Buy, sets target at EUR 4.4

PUBT·09/21/2026 07:00:50
Listen to the news
NuWays initiates Gallmetzer HealthCare with Buy, sets target at EUR 4.4
  • NuWays initiated coverage of Gallmetzer Healthcare with a BUY rating, setting a 12-month target price of EUR 4.4.
  • Thesis centers on organic growth and margin expansion from a vertically integrated dental platform spanning distribution, anesthetics, premium oral care.
  • NuWays forecasts 7.7% organic revenue CAGR through FY30, projecting EBITDA margin expansion of 5.2 percentage points to 6.9%.
  • Gerhò distribution unit cited as a resilient, cash-generative base, supported by a rising private-label mix.
  • Intermedical Pharma dossiers, European M&A, international expansion flagged as potential catalysts for faster growth and earnings momentum.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gallmetzer Healthcare S.p.A. published the original content used to generate this news brief via EQS News (Ref. ID: rc_26854) on September 21, 2026, and is solely responsible for the information contained therein.